Skip to main content

Advertisement

Table 3 Postprandial area under the curve data of pre-diabetic subjects before and after an eight week intervention of ALCA or placebo

From: Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics

Variable Pre Intervention ALCA Post Intervention ALCA Pre Intervention Placebo Post Intervention Placebo
Malondialdehyde (μmol·L-1·6 hr-1) 9.66 ± 1.33 9.39 ± 1.17 9.56 ± 1.15 9.26 ± 1.07
Xanthine Oxidase (mU·mL-1·6 hr-1) 67.77 ± 7.70 67.45 ± 9.24 74.11 ± 8.58 76.91 ± 10.39
Hydrogen Peroxide (μmol·L-1·6 hr-1) 84.76 ± 13.15 81.25 ± 14.87 79.65 ± 12.47 86.45 ± 15.43
Triglyceride (mg·dL-1·6 hr-1) 585.00 ± 74.22 580.50 ± 73.84 612.95 ± 92.98 597.08 ± 70.43
Glucose (mg·dL-1·6 hr-1) 658.00 ± 56.27 640.18 ± 73.71 683.00 ± 67.82 679.45 ± 54.46
TEAC (mmol·L-1·6 hr-1) 3.30 ± 0.19 3.45 ± 0.18 3.25 ± 0.21 3.28 ± 0.19
Nitrate/Nitrite (μmol·L-1·6 hr-1) 139.50 ± 18.35 172.40 ± 21.75 128.70 ± 11.75 130.45 ± 10.15
  1. Data are mean ± SEM.
  2. No statistically significant differences noted (p > 0.05).